MedPage Today on MSN
Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer
SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...
Nadunolimab combined with chemotherapy showed no significant efficacy improvement in metastatic TNBC, despite surpassing ...
The phase 3 MajesTEC-3 trial demonstrated that the combination of the bispecific BCMA-directed T-cell engager teclistamab and ...
TipRanks on MSN
Lytix Biopharma’s promising update: Phase 2 study on advanced melanoma treatment completed
Lytix Biopharma AS ($DE:6BG) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 2 Study of ...
BioInvent International AB ($BOVNF) announced an update on their ongoing clinical study. Study Overview: BioInvent International AB, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback